期刊文献+

miR-4686对A549细胞球增殖的调控作用及其机制研究 被引量:1

Regulation of miR-4686 on proliferation in A549 spheres
下载PDF
导出
摘要 目的研究miR-4686对A549细胞球增殖的调控作用及其相关机制。方法培养A549细胞,从中分选出CD133+CD44+A549细胞并置于无血清培养基中培养,形成细胞球后进行CD133+CD44+表达检测。Western blot检测A549细胞和A549细胞球中Wnt5a、Wnt2蛋白的表达;合成miR-4686抑制物和阴性对照,分别转染A549细胞球48 h后,应用Real-time PCR检测转染前后miR-4686的表达变化后,使用Real-time PCR和Western blot分析Wnt5a、Wnt2以及β-catenin mRNA和蛋白的表达变化,利用MTT检测12、24、48 h细胞的增殖能力。结果流式细胞术检测A549细胞球CD133+CD44+表达为69.800%;A549细胞球分别转染miR-4686抑制物和阴性对照物后,miR-4686的表达以及Wnt5a、Wnt2和β-catenin mRNA和蛋白的表达较对照组和miR-4686阴性对照物组显著下调(P<0.05);A549细胞球转染miR-4686抑制物后12、24、48 h,其OD值显著低于对照组和miR-4686对照物干预组(P<0.05)。结论 miR-4686介导Wnt信号通路发挥调控A549细胞球增殖的作用,其可成为治疗肺癌的潜在靶点。 Objective To study the mechanism of miR-4686 regulating the proliferation of A549 spheres.Methods CD133+CD44+A549 cells were sorted by FACS, and then cultured in serum-free medium. Positive rate of CD133+CD44+ A549 spheres were detected by FACS. Wnt5a and Wnt2 protein expression of A549 cells and A549 spheres were assayed by Western blotting. MiR-4686 inhibitors and negative control were synthesized. A549 spheres were treated with miR-4686 inhibitors and negative control separately for 48 h, and then the expression of miR-4686 were detected by real-time PCR. Wnt5a, Wnt2 and β-catenin mRNA and protein expression was assayed by RT-PCR and Western blotting, respectively. The proliferation of A549 spheres was detected by MTT assay at 12, 24 and 48 h.Results CD133+CD44+ A549 cells were sorted. The positive rate of CD133+CD44+ was 69.800% in A549 spheres. Wnt5a and Wnt2 protein expression was significant decreased in A549 cells, as compared to A549 spheres (P〈0.05). After treatment with miR-4686 inhibitors, the expression of miR-4686 as well as the mRNA and protein expression of Wnt5a, Wnt2 and β-catenin were significant down-regulated, compared to the control group and miR-4686 negative control group (P〈0.05). What’s more, OD values at 12, 24 and 48 h were decreased after miR-4686 inhibitor treatment (P〈0.05).Conclusion MiR-4686 plays an important role in regulation of A549 sphere proliferation through Wnt signal pathway, which may become a novel target for treatment of non-small-cell lung cancer.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2014年第4期340-345,共6页 Journal of Third Military Medical University
基金 国家自然科学基金重大项目(2011YQ170067) 国家自然科学基金(81160293) 江西省教育厅青年科学基金(GJJ10067)~~
关键词 MICRORNA 抑制物 CD133 肺癌 microRNA inhibitors CD133 lung cancer
  • 相关文献

参考文献23

  • 1Baek D,Villen J,Shin C. The impact of microRNAs on protein output[J].{H}NATURE,2008,(7209):64-71.
  • 2Bartel D P. MicroRNAs:target recognition and regulatory functions[J].{H}CELL,2009,(2):215-233.
  • 3Chang T C,Mendell J T. microRNAs in vertebrate physiology and human disease[J].{H}Annual Review of Genomics and Human Genetics,2007.215-239.
  • 4Garzon R,Calin G A,Croce C M. MicroRNAs in Cancer[J].{H}Annual Review of Medicine,2009.167-179.
  • 5Yi R,Fuchs E. MicroRNAs and their roles in mammalian stem cells[J].{H}Journal of Cell Science,2011,(Pt 11):1775-1783.
  • 6Teng Y,Wang X,Wang Y. Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells[J].{H}Biochemical and Biophysical Research Communications,2010,(3):373-379.
  • 7孙芬芬,贺斌峰,余时沧,黄学德,叶小群.A549肺癌细胞球抗凋亡能力及耐药蛋白表达分析[J].肿瘤,2011,31(2):111-116. 被引量:9
  • 8Eramo A,Lotti F,Sette G. Identification and expansion of the tumorigenic lung cancer stem cell population[J].{H}Cell Death and Differentiation,2008,(3):504-514.
  • 9Heinrich E M,Dimmeler S. MicroRNAs and stem cells:control of pluripotency,reprogramming,and lineage commitment[J].{H}CIRCULATION RESEARCH,2012,(7):1014-1022.
  • 10Berezikov E,Guryev V,van-de-Belt J. Phylogenetic shadowing and computational indentification of human microRNA genes[J].{H}CELL,2005,(1):21-24.

二级参考文献18

  • 1CLARKE M F, DICK J E, DIRKS P B, et al. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem celrs[J]. Cancer Res, 2006, 66 (19): 9339-9344.
  • 2AI-HAJJ M, WlCHA M S, BENITO-HERNANDEZ A, et al. Prospective identification of tumorigenic b'reast cancer cells[J]. Proc Natl Acad Sci USA, 2003, 100(7): 3983-3988.
  • 3DEAN M, FOJO T, BATES S. Tumour stem cells and drug resistance[J]. Nat Rev Cancer, 2005, 5(4): 275-284.
  • 4ERAMO A, LOTTI F, SETTE G, et al. Identification and expansion of the tumorigenic lung cancerstem cell population[J]. Cell Death Differ, 2008, 15(3): 504-514.
  • 5YU S C, PING Y F, YI L, et al. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87[J]. Cancer Lett, 2008, 265(1):124-134.
  • 6YANG L, ZHOU X, YANG J, et al. Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro[J]. J Neuroimmunol, 2008, 199(1/2): 10-17.
  • 7ZHAO C, CHEN A, JAMIESON C H, eta/. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia[J]. Nature, 2009, 458(7239): 776-779.
  • 8GAVIRAGHI M, TUNICI P, VALENSIN S, et al. Pancreatic cancer spheres are more than just aggregates of stem marker positive cells[J]. BiosciRep, 2010, 31(1): 45-55.
  • 9ALAJEZ N M, SHI W, HUI A B, et al. Targeted depletion of BMIl sensitizes tumor cells to P53mediated apoptosis in response to radiation therapy[J]. Cell Death Differ, 2009, 16(11): 1469-1479.
  • 10KIM J K, JUNG K H, NOH J H, et al. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma[J]. IntJ Oncol, 2009, 35(6): 1257-1264.

共引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部